UK digital health company RHYTHM AI has claimed FDA approval for a new version of its algorithm for mapping areas of the heart that are affected by atrial fibrillation (AFib) that will be r
Siemens Healthineers has agreed a €200 million ($224 million) deal to buy the diagnostic arm of Novartis' Advanced Accelerator Applications (AAA) radiopharma unit, boosting its medical imag
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.